Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Emergency Physicians Don’t Follow Evidence When Prescribing Antibiotics, and That Needs to Change

By Ryan Patrick Radecki, MD, MS | on September 14, 2014 | 4 Comments
Pearls From the Medical Literature
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Emergency Physicians Don't Follow Evidence When Prescribing Antibiotics, and That Needs to Change

Modern medicine is stuffed full of egregious waste. Whether unnecessary imaging for lower back pain, scandalous improper use of cardiac stents, or the administrative and regulatory burden on clinicians, there is ample opportunity to improve. However, no part of care should cause us greater shame than our incurable addiction to antibiotic prescribing for benign, self-limited conditions. Astoundingly, four years of medical school and three years or more of specialty training have not yet proven sufficient to prevent clinicians from choosing wrongly in the most basic ambulatory complaints—bronchitis, pharyngitis, and sinusitis.

You Might Also Like
  • Praise for Evidence-Based Advice on Prescribing Antibiotics, Testing Blood Cultures
  • Myths in Emergency Medicine: 24-Hour Treatment with Antibiotics for Strep Throat
  • Antibiotics Provide No Added Benefit in Severe Asthma Flares
Explore This Issue
ACEP Now: Vol 33 – No 09 – September 2014

The treatment for acute bronchitis, for example, is very clearly laid out by the Agency for Healthcare Research and Quality and the National Quality Measures Clearinghouse in the Healthcare Effectiveness Data and Information Set.1 The correct treatment rate for adults ages 18 to 65 who have no comorbid respiratory condition is zero. We should never be prescribing antibiotics in this situation. This is not a surprising or novel recent medical innovation. Uncomplicated acute bronchitis has been established for 40 years as a self-limited condition for which antibiotics have conferred no benefit.2 However, clinicians in the United States—both ambulatory outpatient and emergency department—prescribe antibiotics between 65 percent and 80 percent of the time, a rate that has held steady over the last two decades.3 With literally a million visits to EDs for bronchitis each year, we are causing profound injury to society from the raw costs of antibiotics, adverse reactions to medication, and increased bacteria resistance; this is all completely avoidable.

Uncomplicated acute bronchitis has been established … as a self-limited condition for which antibiotics confer no benefit.

Acute pharyngitis, likewise, is grossly overtreated with antibiotics. The prevalence of pathogenic group A Streptococcus (GAS) in acute pharyngitis is approximately 10 percent, and other concerning pathogens—Fusobacterium and Neisseria, for example—represent a tiny additional fraction.4 There is a widely available rapid antigen test for GAS, and besides, GAS is an otherwise self-limited condition for which antibiotics confer minimal symptom relief. Might it be reasonable to expect prescribing rates would be low? It would. However, 60 percent of visits for uncomplicated acute pharyngitis result in antibiotic prescriptions. If this excessive rate is justified based on prevention of subsequent complications, the rate cannot be justified, as the concern is unfounded. It has been estimated that as many as 4,000 patients need to be treated with antibiotics for GAS infection to prevent a single case of peritonsillar abscess.5 Rheumatic fever, the scourge of previous generations, has been eliminated in the United States, with multiple hypotheses, including simple improved hygiene, changes in host factors, and decline in rheumatogenic strains, thought to be the cause.6 David Newman, MD, even makes a very reasonable case for cessation of treatment of GAS with antibiotics, estimating it requires more than 100,000 patients to be treated to prevent a single case of rheumatic fever.7 This rate of complications is far lower than the expected rate of anaphylactic and adverse reactions from antibiotic treatment; therefore, antibiotics for strep throat may do more harm than good. At minimum, however, testing and treatment should be guided by validated clinical criteria and use of rapid antigen testing, which should dramatically decrease the rate of prescribing in acute pharyngitis.

Pages: 1 2 3 | Single Page

Topics: AntibioticsEmergency MedicineEmergency PhysicianPractice Trends

Related

  • EM Runs in the Family

    February 26, 2025 - 0 Comment
  • Settling the Cefepime versus Piperacillin-Tazobactam Debate

    November 7, 2024 - 0 Comment
  • 2024–2025 Emergency Physician Compensation Report

    September 6, 2024 - 4 Comments

Current Issue

ACEP Now: July 2025

Download PDF

Read More

About the Author

Ryan Patrick Radecki, MD, MS

Ryan Patrick Radecki, MD, MS, is an emergency physician and informatician with Christchurch Hospital in Christchurch, New Zealand. He is the Annals of Emergency Medicine podcast co-host and Journal Club editor and can be found on Twitter @emlitofnote.

View this author's posts »

4 Responses to “Emergency Physicians Don’t Follow Evidence When Prescribing Antibiotics, and That Needs to Change”

  1. October 3, 2014

    Anthony Reply

    Dr. Radecki,
    I appreciate the extensive review of the research in regards to the perils of providing antibiotics to mostly viral etiologies. When people do things contrary to the evidence and rational thought it sometimes is helpful to ask why. It might be helpful to review: “The Real Reason People Won’t Change” HBR November 2001 by Robert Kegan and Lisa Laskow Lahey.
    Good work.
    Anthony

  2. May 27, 2015

    New Treatment for Recurrent C. difficile Shows Promise - ACEP Now Reply

    […] is often triggered by exposure to antibiotics, particularly in the elderly, and has a recurrence rate of 25 to 30 percent among affected […]

  3. September 16, 2015

    Many Hispanic Adults Still Believe Antibiotics Will Treat a Cold - ACEP Now Reply

    […] U.S. adults, including almost half of Hispanics, believe that taking antibiotics will ease the symptoms of a cold, a new study shows, even though most colds are viral and […]

  4. April 23, 2023

    TED WESLEY SWITZER Reply

    I appreciate the article and advice to EM physicians to limit the use of antibiotics in acute pharyngitis and other respiratory infections.
    However, in my experience, it may be even more important that this message be delivered to non-physician midlevel providers who very frequently prescribe a Z-pak and steriods for every sore throat, sinusitis and bronchitis that walks through the door.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603